Addiction & Substance Use

Medication, counseling, and support—just as important in substance use disorder treatment as any other brain disease.

Cannabis use disorder and nonadherence: How can we best educate patients?

The experts weighed in on a wide variety of psychiatric issues for the July 2022 issue of Psychiatric Times.

Positive results from the phase 3 trial of AD04 show a 79% reduction in heavy drinking.

What happens when a clinician is faced with addiction in their own family?

New results are coming for AD04, a potential treatment for patients with alcohol use disorder.

Treatment deserts are adding fuel to the fire of the opioid crisis.

What is the clinician’s role in reversing stigma for better outcomes?

The experts weighed in on a wide variety of psychiatric issues for the June 2022 issue of Psychiatric Times.

Understanding the intersection between substance misuse and acquired brain injury can assist clinicians in accurately diagnosing and treating these cooccurring conditions.

Clinicians are trained in how to help patients with substance use disorders—but what happens when the individual with a substance use disorder is a loved one?

In this CME, review the clinical, legal, and ethical aspects of the civil commitment for substance use disorders.

Understanding the additive effects of stigma surrounding dual diagnosis with both substance use disorder and a mental illness.

What's the latest update on cannabis legislation and its clinical utility?

"Limiting definitions of recovery to abstinence and the absence of AUD symptoms fail to capture the multidimensional and heterogeneous pathways to recovery that research has shown to exist among both treatment-seeking and population samples."

The prevalence of annual alcohol consumption is highest in full-time college students 1 to 4 years after high school.

A look at the latest in evidence-based care and innovative treatment for substance use and addiction.

Recovery from addiction does not protect against normal life events...

Some of the more severe ADHD symptoms noted were depression/withdrawal, problems with socialization.

Strategy highlights plans of action to address untreated addiction, overdose epidemic.

If you missed out on the custom Around the Practice video program on naloxone, we've got you covered. Read a recap here.

The panel concludes our discussion with the role healthcare providers play today in the treatment of opioid overdose and what needs to change for the future.

Our experts provide their expertise on Patient Case 2 and how they would proceed with treatment.

Dr Torrington moves on to Patient Case 2, a 49-year-old man found semi-responsive with a suspected opioid overdose.

The group discusses Patient Case 1 and how they would treat in this scenario.

Matthew A. Torrington, MD, introduces our first patient case, a 27-year-old man presenting with injuries from a car accident.

Can a game improve children and adolescents knowledge of the opioid crisis?

30% to 60% of individuals seeking treatment for SUD also meet criteria for PTSD.